Publication
2013
Economic Analyses to Support Decisions about HPV Vaccination in Low- and Middle-Income Countries: Consensus Report and Guide
Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability …
Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries. The expert group…
Costing Methods
|
Health Outcomes
|
Economics/Finance
|
Middle East & North Africa
|
Sub-Saharan Africa
|
Cost-Effectiveness Analysis
|
Infectious Diseases
|
Chronic Disease/Risk
|
Health Systems
|
Health/Medicine
|
Science/Technology
|
Latin America & Caribbean
|
Asia & Pacific